Evaluation of Goal-Directed Intraoperative Hemodynamic Optimization Protocol

August 20, 2023 updated by: University of California, Irvine
As part of a quality assurance program, the Department of Anesthesiology implemented a Goal-Directed Fluid Management training course for all physicians and nurses to provide goal-directed fluid management. We intend to assess whether there has been any improvement in patient outcomes by analyzing de-identified clinical information that are readily available via the medical center electronic medical record system. The time-frame we are interested in is one year before and one year after the Goal-Directed Fluid Management training curriculum (June 15, 2011 to September 15, 2013).

Study Overview

Status

Completed

Detailed Description

A number of published studies in anesthesia have demonstrated that certain patient factors may impact patient perioperative outcomes. Factors such as age, gender, cardiac function, and hemodynamic status all have been shown to be predictive indicators. The goal of the present study is to evaluate these factors with the effectiveness of the Goal Directed Fluid Management training on patient outcomes after major surgeries and document the final perioperative outcomes.

This is an observational study in which patients' de-identified clinical information will be extracted from the University of California, Irvine Medical Center electronic medical record system to evaluate whether there has been a change in patients' outcomes after the Goal-Directed Fluid Management training curriculum was implemented. We will extract data from both before and after the training took place-- the time-frame is from June 15, 2011 to September 15, 2013. Specifically we will be looking at 30 day re-admission and 90 day mortality following surgery. There are no study procedures or use of biological material. Patient identifies are utilized in the secure database as this is utilized for clinical management. When the data is extracted from the database for research purposes the patient identifiers will be removed and no patient identifiers will be included in the information during statistical analysis or subsequent reporting. For publication, only aggregate data is utilized. No identifiable patient information will be released at any time.

Statistical considerations may include: Sample Size Considerations, Predictors, Covariates/Cofounders, Statistical Goal(s), Statistical Approach, and Secondary Analysis. Specifically, statistical analysis will be performed using computerized software (SPSS for Windows version 12.0). For data that was non-normally distributed a Mann Mann-Whitney test will be used and normally distributed data will be compared using the Student T-test. Ordinal and nominal data will compared using Chi-Square analysis. A p value smaller or equal to 0.05 will be considered significant. These statistical considerations will aid in supporting the study's hypothesis for patient outcomes improvement with Early Goal Directed Fluid Management training.

Study Type

Observational

Enrollment (Actual)

330

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Orange, California, United States, 92868
        • UC Irvine Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The characteristics for inclusion of the proposed subject population will include those adults patients who have undergone one or more of the following high risk surgeries: liver resection, pancreatectomy, cancer debulking, colorectal surgery, and receive arterial line as directed by the attending anesthesiologist as standard care of patient. Emergent surgical procedures will not be considered for this study.

Description

Inclusion Criteria:

  • Patients aged 18 years or older,
  • Patients undergoing one or more of the following high risk surgeries: liver resection, pancreatectomy, cancer debulking, colorectal surgery,
  • Surgical procedures must be projected to last longer than 2 hours,
  • Patients receiving

Exclusion Criteria:

  • Pregnant
  • Under 18 years of age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Before GDFM Training
Approximate 300 patients' medical record information will be extracted from the UC Irvine Medical Center electronic medical record prior to the start of the training curriculum.
After GDFM Training
Approximate 300 patients' medical record information will be extracted from the UC Irvine Medical Center electronic medical record after the training program took place

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The difference in length of stay in the hospital after surgery between pre-curriculum and post-curriculum cohorts.
Time Frame: records will be assessed an expected average of 1 year before curriculum (June 2011) and 1 year after curriculum (September 2013) June 15, 2011- September 15, 2013
Length of stay in the hospital (number of nights) after the surgery
records will be assessed an expected average of 1 year before curriculum (June 2011) and 1 year after curriculum (September 2013) June 15, 2011- September 15, 2013

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of surgical site infection
Time Frame: 30 days after surgery
Surgical site infection defined according to the NSQIP database
30 days after surgery
Incidence of postoperative pneumonia
Time Frame: 30 days after surgery
Pneumonia defined according to the NSQIP database
30 days after surgery
Incidence of urinary tract infection
Time Frame: 30 days after surgery
Urinary tract infection defined according to the NSQIP database
30 days after surgery
Incidence of myocardial infarction
Time Frame: 30 days after surgery
Myocardial infarction defined according to the NSQIP database
30 days after surgery
Incidence of deep vein thrombosis
Time Frame: 30 days after surgery
Deep vein thrombosis defined according to the NSQIP database
30 days after surgery
Incidence of atrial fibrillation
Time Frame: 30 days after surgery
Atrial fibrillation defined according to the NSQIP database
30 days after surgery
Incidence of sepsis
Time Frame: 30 days after surgery
Sepsis defined according to the NSQIP database
30 days after surgery
30 days readmission rate
Time Frame: 30 days after discharge from hospital
Unplanned readmission within 30 days after hospital discharge.
30 days after discharge from hospital
Incidence of intraoperative transfusion
Time Frame: intraoperatively (Day 1, during surgery)
Blood product transfusion during surgery
intraoperatively (Day 1, during surgery)
Incidence of post anesthesia care unit transfusion
Time Frame: 30 days after surgery in the PACU
Blood product transfusion in the post anesthesia care unit (PACU)
30 days after surgery in the PACU

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maxime Cannesson, MD, PhD, UC Irvine Medical Center, Dept. of Anesthesiology & Perioperative Care

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2013

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

October 1, 2016

Study Registration Dates

First Submitted

December 17, 2013

First Submitted That Met QC Criteria

February 5, 2014

First Posted (Estimated)

February 7, 2014

Study Record Updates

Last Update Posted (Actual)

August 23, 2023

Last Update Submitted That Met QC Criteria

August 20, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20139795
  • UCIANES04 (Other Identifier: University of California, Irvine)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Subscribe